Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1996
12/24/1996US5587458 Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
12/24/1996US5587457 Neutrophil stimulating peptides
12/24/1996US5587455 Hybrid protein comprising virus binding region from cd4 cellular receptor sequence linked to protein toxin sequence containing region essential for cell toxicity
12/24/1996US5587454 Omega conopeptide compositions
12/24/1996US5587388 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof
12/24/1996US5587375 Azepinone compounds useful in the inhibition of ACE and NEP
12/24/1996US5587366 Compositions useful in prophylaxis and therapy of endotoxin related conditions
12/24/1996US5587360 Platelet adhesion inhibitor
12/24/1996US5587359 Human derived glycoprotein, biologically active factor which includes glycoprotein and pharmaceutical product
12/24/1996US5587358 Potentiators of antimicrobial activity
12/24/1996US5587310 Coagulation factor v in which 1 to 5 a3 domain exons are replaced with homologous exons of coagulation factor viii
12/24/1996US5587308 Modified adeno-associated virus vector capable of expression from a novel promoter
12/24/1996US5587306 Dna sequences
12/24/1996US5587302 T cell growth factor
12/24/1996US5587162 Administering to mammal a cytotoxin
12/24/1996US5587159 Human tissue plasminogen activator
12/24/1996CA2030174C Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
12/24/1996CA2020752C Treatment of bone disorders
12/24/1996CA1338807C Plasmid vector with pectate lyase signal sequence
12/19/1996WO1996041191A1 Methods and uses for apoptin
12/19/1996WO1996041020A1 Fluorescence resonance energy transfer screening assay for the identification of hiv-1 envelope glycoprotein-medicated cell
12/19/1996WO1996040977A1 Origin of replication complex genes
12/19/1996WO1996040966A1 Compositions and methods of treating il-6 associated diseases
12/19/1996WO1996040963A1 Cationic lipid:dna complexes for gene targeting
12/19/1996WO1996040962A1 Cationic lipid:dna complexes for gene targeting
12/19/1996WO1996040959A1 Cell line producing analgesic compounds for treating pain
12/19/1996WO1996040948A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN
12/19/1996WO1996040943A1 Use of gram-positive bacteria to express recombinant proteins
12/19/1996WO1996040942A1 Humanized antibodies to e-selectin
12/19/1996WO1996040940A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
12/19/1996WO1996040937A2 Adenosine kinase polynucleotides
12/19/1996WO1996040932A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996WO1996040931A1 Neutralizing conformational epitopes of chicken anemia virus
12/19/1996WO1996040930A1 Mutants of streptococcal toxin a and methods of use
12/19/1996WO1996040928A1 Streptococcal heat shock proteins members of the hsp70 family
12/19/1996WO1996040927A1 Isospora suis vaccine
12/19/1996WO1996040926A2 Detection of cryptosporidium parvum
12/19/1996WO1996040923A1 Macrophage derived chemokine and chemokine analogs
12/19/1996WO1996040922A1 Novel serpin derived from human hypothalamus
12/19/1996WO1996040921A1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof
12/19/1996WO1996040920A1 Modified hemoglobin-like compounds and methods of purifying same
12/19/1996WO1996040918A2 Novel cd40l mutein
12/19/1996WO1996040916A1 Icam-4 materials and methods
12/19/1996WO1996040915A2 Novel ctla4/cd28 ligands and uses therefor
12/19/1996WO1996040914A1 Truncated hepatocyte growth factor variants
12/19/1996WO1996040912A1 Ob protein compositions and method
12/19/1996WO1996040911A1 Modified steroid hormones for gene therapy and methods for their use
12/19/1996WO1996040910A1 Human growth factors, nucleotide sequence encoding growth factors, and methods of use thereof
12/19/1996WO1996040909A1 Bone stimulating factor
12/19/1996WO1996040908A1 OLIGONUCLEOTIDES SPECIFIC FOR CYTOKINE SIGNAL TRANSDUCER gp130 mRNA
12/19/1996WO1996040907A1 Interleukin-1 receptor intracellular ligand proteins and inhibitors of ligand binding
12/19/1996WO1996040906A1 Optimized minizymes and miniribozymes and uses thereof
12/19/1996WO1996040903A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996WO1996040894A1 Treatment of insulin resistance
12/19/1996WO1996040893A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
12/19/1996WO1996040884A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
12/19/1996WO1996040878A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
12/19/1996WO1996040877A1 Immortalization and disimmortalization of cells
12/19/1996WO1996040868A1 Essential oligonucleotides of vertebrate telomerase
12/19/1996WO1996040865A1 Replacement therapy for dental caries
12/19/1996WO1996040864A1 A novel protein, faf1, which potentiates fas-mediated apoptosis and uses thereof
12/19/1996WO1996040829A1 Crosslinkable polypeptide compositions
12/19/1996WO1996040789A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES
12/19/1996WO1996040788A1 Anti-allergy bispecific molecules
12/19/1996WO1996040786A1 Lymphocyte chemoattractant factor and uses thereof
12/19/1996WO1996040784A2 Method of solubilizing, purifying, and refolding protein
12/19/1996WO1996040782A1 Separation of hemoglobin on hydroxyapatite using hplc
12/19/1996WO1996040781A1 CYCLIC PEPTIDE INHIBITORS OF β1 AND β2 INTEGRIN-MEDIATED ADHESION
12/19/1996WO1996040779A1 Peptide fragments of tissue factor and their use for treatment and prevention of clotting disorders
12/19/1996WO1996040778A1 TCR Vβ5 PEPTIDES
12/19/1996WO1996040777A2 Synthetic peptides and pharmaceutical compositions comprising them
12/19/1996WO1996040775A1 Method for the treatment of corticosteroid induced osteopenia
12/19/1996WO1996040774A1 Complexes of modified lymphotoxins as pharmaceutical preparations
12/19/1996WO1996040772A2 Agonist peptide dimers
12/19/1996WO1996040771A1 SINGLE CHAIN ANALOGS OF THE TGF-β SUPERFAMILY (MORPHONS)
12/19/1996WO1996040770A2 Anti-fungal d-amino acid histatin-based peptides
12/19/1996WO1996040769A1 Developmentally-regulated endothelial cell locus-1
12/19/1996WO1996040768A2 Anti-fungal and anti-bacterial histatin-based peptides
12/19/1996WO1996040767A2 E6ap-binding proteins
12/19/1996WO1996040765A1 PROMOTION OF HOMOLOGOUS DNA PAIRING BY RecA-DERIVED PEPTIDES
12/19/1996WO1996040762A1 Monocyte chemotactic protein-4
12/19/1996WO1996040760A2 Iodine-containing peptides and their use as x-ray contrast media
12/19/1996WO1996040759A1 Antiviral peptoid compounds
12/19/1996WO1996040757A2 Lhrh antagonist peptides
12/19/1996WO1996040756A1 Radiometal-binding analogues of leutenizing hormone releasing hormone
12/19/1996WO1996040754A1 Immunogenic peptides of prostate specific antigen
12/19/1996WO1996040753A1 Pipecolic acid derivatives of proline threonine amides useful for the treatment of rheumatoid arthritis
12/19/1996WO1996040752A1 Novel dolastatin derivatives, their preparation and use
12/19/1996WO1996040751A1 Novel dolastatin derivatives, their preparation and use
12/19/1996WO1996040750A1 Peptides and compounds that bind to a thrombopoietin receptor
12/19/1996WO1996040749A1 Compounds and peptides that bind to the erythropoietin receptor
12/19/1996WO1996040748A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders
12/19/1996WO1996040747A1 Urokinase receptor ligands
12/19/1996WO1996040746A1 Lysyloxidase inhibitors
12/19/1996WO1996040745A2 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
12/19/1996WO1996040744A1 KETOHETEROCYCLIC INHIBITORS OF FACTOR Xa
12/19/1996WO1996040743A2 INHIBITORS OF FACTOR Xa
12/19/1996WO1996040742A1 Peptidyl heterocycles useful in the treatment of thrombin relateddisorders
12/19/1996WO1996040741A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders
12/19/1996WO1996040740A1 Peptide and method of obtaining it
1 ... 2744 2745 2746 2747 2748 2749 2750 2751 2752 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 ... 3163